The interleukin-23 (IL-23)-T-helper 17 (Th17) axis is a central and non-redundant mediator of immunity to OPC, and anti-cytokine biologics targeting IL-23 have come into widespread clinical use for treating various autoimmune conditions. Here, IL37 is linked to Autoimmunity.